Technical Analysis for MBVX - Mabvax Therapeutics Holdings Inc

Grade Last Price % Change Price Change
grade F 0.1106 -5.87% -0.0069
MBVX closed down 5.87 percent on Monday, March 25, 2019, on 3.55 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical MBVX trend table...

Date Alert Name Type % Chg
Volume Surge Other 0.00%
Narrow Range Bar Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%

Older signals for MBVX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

MabVax Therapeutics Holdings, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes proprietary human monoclonal antibody products and vaccines for the treatment of various cancers. The company has a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been immunized against targeted cancers. Its lead cancer vaccines targeting recurrent sarcoma and ovarian cancer are in proof of concept Phase II multi-center clinical trials. The company's product candidates include MVT-5873, a therapeutic antibody that is in Phase I clinical trial for patients with advanced or metastatic adenocarcinoma of the pancreas (PDAC) and other CA19-9 positive malignancies; and MVT-2163, an immuno-positron emission tomography (PET) imaging agent, which is in Phase I clinical trial designed to evaluate a next generation diagnostic PET imaging agent in patients with PDAC or other CA19-9 positive malignancies. Its product candidates also comprise MVT-1075, a radioimmunotherapy agent that combines the company's HuMab-5B1 antibody with the radiopharmaceutical (177) Lutetium to treat pancreatic cancer. The company has various research agreements and collaborations with Memorial Sloan Kettering Cancer Center; a licensing agreement with Life Technologies Corporation; a research collaboration agreement with Rockefeller University's Laboratory of Molecular Genetics and Immunology; and a development and manufacturing services agreement with Patheon. MabVax Therapeutics Holdings, Inc. was founded in 2006 and is based in San Diego, California.
Medicine Medical Specialties Clinical Medicine Imaging Cancers Monoclonal Antibodies Tomography Stage Biopharmaceutical Ovarian Cancer Pancreatic Cancer Monoclonal Antibody Therapy Treatment Of Various Cancers Lead Cancer Manufacturing Services Agreement Memorial Sloan Kettering Cancer Center Metastatic Adenocarcinoma
Is MBVX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 1.05
52 Week Low 0.1
Average Volume 32,253
200-Day Moving Average 0.0
50-Day Moving Average 0.2742
20-Day Moving Average 0.2609
10-Day Moving Average 0.2397
Average True Range 0.0727
ADX 17.34
+DI 18.5766
-DI 26.9974
Chandelier Exit (Long, 3 ATRs ) 0.1637
Chandelier Exit (Short, 3 ATRs ) 0.3181
Upper Bollinger Band 0.3836
Lower Bollinger Band 0.1382
Percent B (%b) -0.11
BandWidth 94.059026
MACD Line -0.0279
MACD Signal Line -0.0105
MACD Histogram -0.0173
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1601
Resistance 3 (R3) 0.1641 0.1515 0.1519
Resistance 2 (R2) 0.1515 0.1389 0.1496 0.1491
Resistance 1 (R1) 0.1311 0.1311 0.1248 0.1271 0.1463
Pivot Point 0.1185 0.1185 0.1154 0.1166 0.1185
Support 1 (S1) 0.0981 0.1059 0.0918 0.0941 0.0749
Support 2 (S2) 0.0855 0.0981 0.0836 0.0721
Support 3 (S3) 0.0651 0.0855 0.0694
Support 4 (S4) 0.0611